Cargando…

Successful Treatment of Central Nervous System Post-Transplant Lymphoproliferative Disease With a Reduced Dose of High-Dose Methotrexate

Post-transplant lymphoproliferative disease (PTLD) is a complication of solid organ and hematopoietic stem cell transplantation that occurs as a result of immunosuppression. PTLD isolated to the central nervous system (CNS) is a rare disease and it presents with nonspecific signs and symptoms. Optim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albusoul, Linda, Abu-Hashyeh, Ahmad, Donthireddy, Vijayalakshmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840453/ https://www.ncbi.nlm.nih.gov/pubmed/36654557 http://dx.doi.org/10.7759/cureus.32567

Ejemplares similares

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
por: Twist, Clare J., et al.
Publicado: (2013)

Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report
por: Dimassi, Ahmad B, et al.
Publicado: (2020)

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy
por: Luo, Qian, et al.
Publicado: (2021)

Methotrexate-associated lymphoproliferative disorders in the central nervous system and stomach: A case report
por: Kawazoe, Mai, et al.
Publicado: (2020)

Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy
por: Inoue, Hiroaki, et al.
Publicado: (2020)

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Yang, Ting-Ting, et al.
Publicado: (2021)

PD-1 Blockade Aggravates Epstein–Barr Virus(+) Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4(+) T Cell Dysregulations
por: Volk, Valery, et al.
Publicado: (2021)

Primary Central Nervous System T-cell Lymphoma as Methotrexate-associated Lymphoproliferative Disorders: Case Report
por: KAWANO, Hiroto, et al.
Publicado: (2021)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
por: Yan, Nan, et al.
Publicado: (2021)

Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential
por: White, Matthew L., et al.
Publicado: (2019)

Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
por: Lückemeier, Philipp, et al.
Publicado: (2023)

Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
por: Butzmann, Alexandra, et al.
Publicado: (2022)

Erratum: Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
Publicado: (2023)

Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Diagnosed by Peripheral Facial Nerve Palsy
por: Imafuku, Aya, et al.
Publicado: (2018)

High-Dose Methotrexate for the Treatment of Relapsed Central Nervous System Erdheim-Chester Disease
por: Ho, Prahlad, et al.
Publicado: (2014)

Methotrexate-associated lymphoproliferative disorder with hypopituitarism and central diabetes insipidus
por: Aoshima, Misaki, et al.
Publicado: (2019)

High‐dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma
por: Akiyama, Hiroki, et al.
Publicado: (2016)

Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy
por: Khakwani, Mehnaz, et al.
Publicado: (2022)

A Rare Presentation of Concomitant Lung Disease and Hepatitis After Rituximab Treatment: A Case Report
por: Albusoul, Linda, et al.
Publicado: (2023)

Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide
por: Toyosaki, Masako, et al.
Publicado: (2018)

Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience
por: Sakamoto, Hikaru, et al.
Publicado: (2019)

Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
por: Ueno, Hiroki, et al.
Publicado: (2022)

Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma
por: Lee, Tae Hoon, et al.
Publicado: (2020)

Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
por: Bazan, F., et al.
Publicado: (2019)

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma
por: Bernard, S., et al.
Publicado: (2021)

A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
por: Villanueva, Gabriela, et al.
Publicado: (2023)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Primary Central Nervous System Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis: Case Report and Review of Literature
por: Uneda, Atsuhito, et al.
Publicado: (2020)

Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact
por: Ferla, Valeria, et al.
Publicado: (2020)

Post-transplant lymphoproliferative disease
por: Dharnidharka, Vikas R., et al.
Publicado: (2009)

Ultra-low-dose (boom-boom) radiotherapy for management of recurrent ocular post-transplant lymphoproliferative disorder
por: Astafurov, Konstantin V., et al.
Publicado: (2021)

Successful treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disease with central nervous system involvement following allogeneic haematopoietic stem cell transplantation – a case study
por: Wróblewska, Małgorzata, et al.
Publicado: (2015)

Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
por: Yuan, Xianggui, et al.
Publicado: (2022)

Ocular post-transplant lymphoproliferative disorder
por: Chen, Yun-Wen, et al.
Publicado: (2015)

Post-transplant lymphoproliferative disease of the larynx
por: Vandjelovic, Nathan D, et al.
Publicado: (2019)

Management of post-transplant lymphoproliferative disorders
por: Dierickx, Daan, et al.
Publicado: (2019)

A Case of Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Haploidentical Stem Cell Transplantation in a Patient With Acute Lymphoblastic Leukemia
por: Zhu, Haibo, et al.
Publicado: (2022)

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
por: Namiki, Takeshi, et al.
Publicado: (2018)

Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder
por: Ikeue, Tatsuyoshi, et al.
Publicado: (2019)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ug4ejn87g2blvchhle72tef1gh